Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.

Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
Football Player Asks Friend With Down Syndrome To Homecoming
Man Digging A Duck Pond Uncovers Mysterious Underground Tunnel Made Of Seashells
Hope And Hard Work: Jail Resident Makes History In Clarke County
Chief Of Police Pens Hilarious Letter To Criminals, Suggests Netflix Or Baking
Stranger’s Note Turns A Mother’s Stressful Day Into One She’ll Never Forget
Money Really Does Grow On Trees! Cafés In Ukraine Let Kids 'Buy' Drinks With Leaves They Collected
Mom And Daughter Rock Out In The Car - The Baby’s Reaction Is Priceless!
He Drove Past A Giant Pile Of Leaves, Then Noticed Eyes Staring Back
Bicyclists Come Face-To-Face With Mountain Lion In Terrifying Trail Encounter
Kids At Daycare Take Turns Jumping In A Mud Puddle — And It’s Pure Joy
Angels Walk Among Us: He Needed The Hug More Than The Food
